Evidence map›Paper›PMID 40509830›Full record

ArticleBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences2025

[Type 2 diabetes patients use E-health to manage disease willingness and influence mechanisms].

Z Chen, X Zhang, Y Gu, C Chang

Abstract readEnglish Abstract
In one paragraph

Article in Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Z Chen
X Zhang
Y Gu
C Chang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo comprehensively investigate how the willingness of patients with type 2 diabetes mellitus to use E-health technologies, such as the application (APP) or Wechat mini-programs and the underlying influencing factors works for its mechanisms.

methodsBased on the extended technology acceptance model, a cross-sectional questionnaire survey was conducted among 559 patients with type 2 diabetes from six provinces or municipalities in the eastern, central, and western regions of China from November to December 2024. The survey aimed to investigate the patients' willingness to use APP or Wechat mini-programs and the influencing factors. Correlation analysis and structural equation modeling methods were used to analyze the influencing factors of patients ' willingness to use and to explore the mechanisms.

resultsA total of 559 patients were surveyed, with an average willingness score of 10.68 (out of a total score of 15). Age and education level were found to be influencing factors of willingness to use, younger age and higher education (high school/college) were significantly associated with stronger willingness to use (

conclusionPatients with type 2 diabetes mellitus have a high willingness to use E-health technologies like APP or Wechat mini-programs, particularly younger individuals and those with high school/college education. Increasing perceived usefulness, self-efficacy, and external promotion can enhance willingness to use. However, higher disease perception and higher social support are associated with decreased willingness to use. Perceived ease of use and self-efficacy can also affect willingness to use through multiple mechanisms.

Indexed as

Diabetes Mellitus, Type 2Patient Acceptance of Health CareTelemedicineAdultAgedChinaCross-Sectional StudiesFemaleHumansMaleMiddle AgedSocial SupportSurveys and QuestionnairesE-healthStructural equation modelTechnology acceptance modelType 2 diabetes mellitusWillingness to use

Identifiers

PMID40509830
PMCPMC12171611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.